Insider trades
Santos David A., Chief Officer of Rigel Pharmaceuticals RIGL, has filed 0 purchases and 5 sales on the open market. The latest trade was on 06/17.
Santos David A.
EVP, Chief Commercial Officer
- Company
- Rigel Pharmaceuticals RIGL
- First filing
- 23/01/30
- Trades
- 23 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- No record
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RIGL | Open-market sale | 25/02/04–25/02/05 | 25/02/06 | 3,921 sh2 trades | $21.38avg. | $83,841.28 | −7.0% |
RIGL | Open-market sale | 24/02/02–24/02/05 | 24/02/06 | 14,519 sh2 trades | $1.14avg. | $16,495.65 | −4.0% |
| Open-market sale | 23/02/02 | 23/02/06 | 5,388 sh | $1.66 | $8,944.08 | −3.6% |